Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574301 · ClinicalTrials.gov registry record · Phase 1

Percutaneous Removal and Margin Ablation for Breast Cancer

A Phase 1 study, sponsored by University of Arkansas.

Completed
Registry status
Phase 1
Development phase
32
Enrollment target

NCT00574301: Completed Phase 1 study, sponsored by University of Arkansas.

NCT00574301 is a Phase 1 study that has completed, run by University of Arkansas. The registered enrollment target is 32 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574301, a Phase 1 study, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
Phase 1
Development phase
32 participants
Enrollment target

Study Summary

We hypothesize that radiofrequency ablation after single-insertion image guided vacuum assisted biopsy (IVEB) can be used to achieve negative margins in small unicentric breast cancers (≤1.5 cm).

Interventions

  • PROCEDURE Percutaneous Removal and Margin Ablation

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2002-03
Est. Completion 2011-10
Phase Phase 1
University of Arkansas

318 total trials

What the finished NCT00574301 record still lists

NCT00574301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (47% lower).

The record links to 0 conditions, and to 1 intervention - of which Percutaneous Removal and Margin Ablation is the first listed.

NCT00574301 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00574301 about?

NCT00574301 is a clinical study titled "Percutaneous Removal and Margin Ablation for Breast Cancer". We hypothesize that radiofrequency ablation after single-insertion image guided vacuum assisted biopsy (IVEB) can be used to achieve negative margins in small unicentric breast cancers (≤1.5 cm).

What is the current status of trial NCT00574301?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2002-03. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00574301?

The interventions under investigation include: Percutaneous Removal and Margin Ablation (PROCEDURE).

Who is sponsoring clinical trial NCT00574301?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00574301's enrollment target sits among peer trials

32 1296th of 2000 higher than 679 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00574301, the US trial registry maintained by the National Library of Medicine. NCT00574301 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.